- Home
- AKRO vs SKWD Comparison
AKRO vs SKWD Comparison
Compare AKRO & SKWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- SKWD
- Stock Information
- Founded
- AKRO 2017
- SKWD 2007
- Country
- AKRO United States
- SKWD United States
- Employees
- AKRO N/A
- SKWD N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- SKWD Property-Casualty Insurers
- Sector
- AKRO Health Care
- SKWD Finance
- Exchange
- AKRO Nasdaq
- SKWD Nasdaq
- Market Cap
- AKRO 2.4B
- SKWD 1.9B
- IPO Year
- AKRO 2019
- SKWD 2023
- Fundamental
- Price
- AKRO $28.09
- SKWD $49.79
- Analyst Decision
- AKRO Strong Buy
- SKWD Buy
- Analyst Count
- AKRO 7
- SKWD 10
- Target Price
- AKRO $43.20
- SKWD $46.63
- AVG Volume (30 Days)
- AKRO 617.2K
- SKWD 357.9K
- Earning Date
- AKRO 11-08-2024
- SKWD 10-29-2024
- Dividend Yield
- AKRO N/A
- SKWD N/A
- EPS Growth
- AKRO N/A
- SKWD 54.99
- EPS
- AKRO N/A
- SKWD 3.27
- Revenue
- AKRO N/A
- SKWD $1,092,093,000.00
- Revenue This Year
- AKRO N/A
- SKWD N/A
- Revenue Next Year
- AKRO N/A
- SKWD $10.87
- P/E Ratio
- AKRO N/A
- SKWD $15.23
- Revenue Growth
- AKRO N/A
- SKWD 32.05
- 52 Week Low
- AKRO $14.41
- SKWD $29.40
- 52 Week High
- AKRO $37.00
- SKWD $50.53
- Technical
- Relative Strength Index (RSI)
- AKRO 38.58
- SKWD 69.30
- Support Level
- AKRO $31.12
- SKWD $48.96
- Resistance Level
- AKRO $35.11
- SKWD $50.35
- Average True Range (ATR)
- AKRO 1.99
- SKWD 1.27
- MACD
- AKRO -0.53
- SKWD 0.32
- Stochastic Oscillator
- AKRO 11.68
- SKWD 90.96
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.
About SKWD Skyward Specialty Insurance Group Inc.
Skyward Specialty Insurance Group Inc is a specialty insurance company that delivers commercial property and casualty products and solutions on a non-admitted and admitted basis. The firm has one reportable segment through which it offers a broad array of insurance coverages to several market niches. It operates multiple lines of business, including general liability, excess liability, professional liability, commercial auto, group accident, health, property, surety, and workers' compensation.